North Carolina Vaccine Facility Certified for the Next Pandemic
Seqirus certified to produce 150 million influenza pandemic vaccines
Source: precisionvaccinations.com
📰 Jersey Based Seqirus News
Jersey Based Seqirus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jersey Based Seqirus. Real-time updates on events, politics, business and more.
sa-mRNA Vaccine Production Launches in Massachusetts
New Jersey-based Seqirus today announced a new vaccine research and development facility will open in Massachusetts supporting the company's focus on a self-amplifying messenger RNA (sa-mRNA) technology platform, the next generation of mRNA technology. The new Waltham facility is expected to be fully operational by mid-2022.
United States Noord Holland Roberta Duncan Rna Program Lead At Seqirus Precision Vaccinations Jersey Based Seqirus
Source: precisionvaccinations.com